医药前沿
醫藥前沿
의약전연
Yiayao Qianyan
2015年
30期
34-34,35
,共2页
前列腺增生%经尿道前列腺等离子电切术%临床疗效%并发症
前列腺增生%經尿道前列腺等離子電切術%臨床療效%併髮癥
전렬선증생%경뇨도전렬선등리자전절술%림상료효%병발증
Hyperplasia of prostate%Transurethral resection of prostate electricity cut method%Clinical curative effect%Complications
目的：观察和分析对前列腺增生患者采用经尿道前列腺等离子电切术进行治疗的临床疗效。方法：选取我院2012年10月～2014年10月间收治的160例前列腺增生患者作为临床研究对象，使用随机数字列表法将其随机分为研究组（n=80例）和对照组（n=80例）。对照组80例患者施行经尿道前列腺电切术进行治疗，研究组80例患者施行经尿道前列腺等离子电切术进行治疗。观察两组患者的手术情况及并发症发生情况，并进行对比分析。结果：研究组患者的术中出血量、导管留置时间、住院时间及并发症发生率均明显低于对照组，(P＜0.05)差异均有统计学意义。结论：对前列腺增生患者采用经尿道前列腺等离子电切术进行治疗具有良好的临床价值，且安全性高，值得推广应用。
目的：觀察和分析對前列腺增生患者採用經尿道前列腺等離子電切術進行治療的臨床療效。方法：選取我院2012年10月～2014年10月間收治的160例前列腺增生患者作為臨床研究對象，使用隨機數字列錶法將其隨機分為研究組（n=80例）和對照組（n=80例）。對照組80例患者施行經尿道前列腺電切術進行治療，研究組80例患者施行經尿道前列腺等離子電切術進行治療。觀察兩組患者的手術情況及併髮癥髮生情況，併進行對比分析。結果：研究組患者的術中齣血量、導管留置時間、住院時間及併髮癥髮生率均明顯低于對照組，(P＜0.05)差異均有統計學意義。結論：對前列腺增生患者採用經尿道前列腺等離子電切術進行治療具有良好的臨床價值，且安全性高，值得推廣應用。
목적：관찰화분석대전렬선증생환자채용경뇨도전렬선등리자전절술진행치료적림상료효。방법：선취아원2012년10월～2014년10월간수치적160례전렬선증생환자작위림상연구대상，사용수궤수자렬표법장기수궤분위연구조（n=80례）화대조조（n=80례）。대조조80례환자시행경뇨도전렬선전절술진행치료，연구조80례환자시행경뇨도전렬선등리자전절술진행치료。관찰량조환자적수술정황급병발증발생정황，병진행대비분석。결과：연구조환자적술중출혈량、도관류치시간、주원시간급병발증발생솔균명현저우대조조，(P＜0.05)차이균유통계학의의。결론：대전렬선증생환자채용경뇨도전렬선등리자전절술진행치료구유량호적림상개치，차안전성고，치득추엄응용。
ObjectiveObservation and analysis of prostatic hyperplasia were treated by transurethral resection of prostate electricity cut method for treatment of clinical curative effect.MethodsSelection in October 2012 to October 2012 were 160 cases of patients with hyperplasia of prostate as clinical research object, using the method of random number list will be randomly divided into research group (n = 80 cases) and control group (n = 80). Control group, 80 cases of patients through the urethra prostate electricity cut method treatment, group 80 patients of transurethral prostate plasma cut method for treatment. Observed two groups of patients with surgery and complications, and comparison analysis.ResultsGroup of patients with intraoperative blood loss, catheter indwelling time, length of hospital stay and complication rates were significantly lower than the control group, (P < 0.05) difference had statistical significance. Conclusions For prostatic hyperplasia were treated by transurethral prostatic plasma treatment cut method has good clinical value, and high safety, is worthy of popularization and application.
